干眼症的前沿治疗策略:现状与展望
Cutting-Edge Treatment Strategies for Dry Eye Disease: Current Status and Future Perspectives
DOI: 10.12677/acm.2025.154941, PDF,   
作者: 马 楠, 王理论*:延安大学附属医院眼科,陕西 延安
关键词: 干眼症治疗策略药物物理治疗干细胞Dry Eye Disease Treatment Strategies Drugs Physical Therapy Stem Cells
摘要: 干眼症是一种常见的眼科疾病,严重影响患者的生活质量和视力。随着对干眼症病理生理机制的深入研究,学术界不断探索新的治疗策略。近年来,新型药物的研发、物理治疗方法的改进、干细胞疗法的应用以及创新设备的开发等多种前沿治疗策略相继提出,展现出良好的临床应用前景。现有治疗手段在一定程度上缓解了干眼症的症状,但仍存在疗效不稳定、副作用及个体差异等问题。本文旨在综述干眼症的最新治疗动态,分析当前治疗现状中所面临的挑战,并展望未来可能的研究方向,以期为临床医生和研究者提供有价值的信息,推动干眼症的诊疗进步。
Abstract: Dry eye disease is a widespread ophthalmic condition that significantly impacts patients’ quality of life and visual function. With in-depth research into the pathophysiological mechanisms of dry eye disease, the exploration of treatment strategies in the academic community has also advanced. In recent years, various cutting-edge treatment strategies have been proposed, including the development of novel drugs, improvements in physical therapy methods, the application of stem cell therapy, and the innovation of new devices, all of which demonstrate promising clinical prospects. However, despite the existing treatments alleviating dry eye symptoms to some extent, challenges such as inconsistent efficacy, side effects, and individual variability remain. This article aims to review the latest advancements in dry eye treatment, analyze the challenges in current therapeutic approaches, and explore potential future research directions. It is hoped that this will provide valuable insights for clinicians and researchers, thereby promoting progress in the diagnosis and treatment of dry eye disease.
文章引用:马楠, 王理论. 干眼症的前沿治疗策略:现状与展望[J]. 临床医学进展, 2025, 15(4): 355-361. https://doi.org/10.12677/acm.2025.154941

参考文献

[1] Zhao, X., Jia, Q. and Fu, J. (2023) Effectiveness of rb-bFGF Eye Drops for Post-Cataract Surgery Dry Eye and Observation of Changes in Tear Secretion and Corneal Damage in Patients. Alternative Therapies in Health and Medicine, 29, 489-495.
https://pubmed.ncbi.nlm.nih.gov/37652420/
[2] Huang, D. and Li, Z. (2024) Multidimensional Immunotherapy for Dry Eye Disease: Current Status and Future Directions. Frontiers in Ophthalmology, 4, Article 1449283. [Google Scholar] [CrossRef] [PubMed]
[3] Rastmanesh, R. (2021) Aquaporin5-Targeted Treatment for Dry Eye through Bioactive Compounds and Gut Microbiota. Journal of Ocular Pharmacology and Therapeutics, 37, 464-471. [Google Scholar] [CrossRef] [PubMed]
[4] He, X., Zhao, Z., Wang, S., Kang, J., Zhang, M., Bu, J., et al. (2020) High-Fat Diet—Induced Functional and Pathologic Changes in Lacrimal Gland. The American Journal of Pathology, 190, 2387-2402. [Google Scholar] [CrossRef] [PubMed]
[5] Jackson, C.J., Naqvi, M., Gundersen, K.G. and Utheim, T.P. (2022) Role of Stem Cells in Regenerative Treatment of Dry Eye Disease Caused by Lacrimal Gland Dysfunction. Acta Ophthalmologica, 101, 360-375. [Google Scholar] [CrossRef] [PubMed]
[6] Zemanová, M. (2020) Dry Eyes Disease. A Review. Czech and Slovak Ophthalmology, 77, 107-119. [Google Scholar] [CrossRef] [PubMed]
[7] Sheppard, J.D. and Nichols, K.K. (2023) Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape. Ophthalmology and Therapy, 12, 1397-1418. [Google Scholar] [CrossRef] [PubMed]
[8] King-Smith, P.E., Begley, C. and Braun, R.J. (2022) A Perspective on the Use of Fluorescent Imaging to Reveal Mechanisms of Breakup. Current Eye Research, 47, 1355-1361. [Google Scholar] [CrossRef] [PubMed]
[9] Hong, M., Tong, L., Mehta, J.S. and Ong, H.S. (2023) Impact of Exposomes on Ocular Surface Diseases. International Journal of Molecular Sciences, 24, Article 11273. [Google Scholar] [CrossRef] [PubMed]
[10] Zhuang, D., Misra, S.L., Mugisho, O.O., Rupenthal, I.D. and Craig, J.P. (2023) NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease. International Journal of Molecular Sciences, 24, Article 10866. [Google Scholar] [CrossRef] [PubMed]
[11] Rolando, M. and Barabino, S. (2021) The Subtle Role of Para-Inflammation in Modulating the Progression of Dry Eye Disease. Ocular Immunology and Inflammation, 29, 811-816. [Google Scholar] [CrossRef] [PubMed]
[12] Jeencham, R., Sutheerawattananonda, M., Rungchang, S. and Tiyaboonchai, W. (2020) Novel Daily Disposable Therapeutic Contact Lenses Based on Chitosan and Regenerated Silk Fibroin for the Ophthalmic Delivery of Diclofenac Sodium. Drug Delivery, 27, 782-790. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, H., Li, X., Yang, H., Wang, J., Li, Q., Qu, R., et al. (2020) Nanocomplexes Based Polyvinylpyrrolidone K-17PF for Ocular Drug Delivery of Naringenin. International Journal of Pharmaceutics, 578, Article 119133. [Google Scholar] [CrossRef] [PubMed]
[14] Wiesinger, A., Bigger, B., Giugliani, R., Lampe, C., Scarpa, M., Moser, T., et al. (2024) Development of a Novel Tool for Individual Treatment Trials in Mucopolysaccharidosis. Journal of Inherited Metabolic Disease, 48, e12816. [Google Scholar] [CrossRef] [PubMed]
[15] Caspar, B., Cocchiara, P., Melet, A., Van Emelen, K., Van der Aa, A., Milligan, G., et al. (2022) CXCR4 as a Novel Target in Immunology: Moving Away from Typical Antagonists. Future Drug Discovery, 4, FDD77. [Google Scholar] [CrossRef] [PubMed]
[16] Kletschkus, K., Haralambiev, L., Mustea, A., Bekeschus, S. and Stope, M.B. (2020) Review of Innovative Physical Therapy Methods: Introduction to the Principles of Cold Physical Plasma. In Vivo, 34, 3103-3107. [Google Scholar] [CrossRef] [PubMed]
[17] Ferreira, R.M., Martins, P.N., Pimenta, N. and Gonçalves, R.S. (2022) Measuring Evidence-Based Practice in Physical Therapy: A Mix-Methods Study. PeerJ, 9, e12666. [Google Scholar] [CrossRef] [PubMed]
[18] Chakrabarty, P., Illath, K., Kar, S., Nagai, M. and Santra, T.S. (2023) Combinatorial Physical Methods for Cellular Therapy: Towards the Future of Cellular Analysis? Journal of Controlled Release, 353, 1084-1095. [Google Scholar] [CrossRef] [PubMed]
[19] Wassinger, C.A., Owens, B., Boynewicz, K. and Williams, D.A. (2021) Flipped Classroom versus Traditional Teaching Methods within Musculoskeletal Physical Therapy: A Case Report. Physiotherapy Theory and Practice, 38, 3169-3179. [Google Scholar] [CrossRef] [PubMed]
[20] Ostasevicius, V., Jurenas, V., Venslauskas, M., Kizauskiene, L., Zigmantaite, V., Stankevicius, E., et al. (2024) Low-Frequency Ultrasound for Pulmonary Hypertension Therapy. Respiratory Research, 25, Article No. 70. [Google Scholar] [CrossRef] [PubMed]
[21] Niu, Z.H., Zhao, C.Y. and Jiang, Y.X. (2020) Synergistic Anti-Tumor Mechanisms of Low-Frequency Ultrasound-Targeted Microbubble Destruction: Mechanisms and Application. Acta Academiae Medicinae Sinicae, 42, 540-545.
[22] Mukherjee, S., Yadav, G. and Kumar, R. (2021) Recent Trends in Stem Cell-Based Therapies and Applications of Artificial Intelligence in Regenerative Medicine. World Journal of Stem Cells, 13, 521-541. [Google Scholar] [CrossRef] [PubMed]
[23] Hu, J. and Wang, J. (2019) From Embryonic Stem Cells to Induced Pluripotent Stem Cells—Ready for Clinical Therapy? Clinical Transplantation, 33, e13573. [Google Scholar] [CrossRef] [PubMed]
[24] Qiu, C., Ge, Z., Cui, W., Yu, L. and Li, J. (2020) Human Amniotic Epithelial Stem Cells: A Promising Seed Cell for Clinical Applications. International Journal of Molecular Sciences, 21, Article 7730. [Google Scholar] [CrossRef] [PubMed]
[25] Rahmani-Moghadam, E., Zarrin, V., Mahmoodzadeh, A., Owrang, M. and Talaei-Khozani, T. (2022) Comparison of the Characteristics of Breast Milk-Derived Stem Cells with the Stem Cells Derived from the Other Sources: A Comparative Review. Current Stem Cell Research & Therapy, 17, 71-90. [Google Scholar] [CrossRef] [PubMed]
[26] Jaffet, J., Singh, V., Schrader, S. and Mertsch, S. (2024) The Potential Role of Exosomes in Ocular Surface and Lacrimal Gland Regeneration. Current Eye Research, 1-14. [Google Scholar] [CrossRef] [PubMed]
[27] Khorrami-Nejad, M., Hashemian, H., Majdi, A., Jadidi, K., Aghamollaei, H. and Hadi, A. (2025) Application of Stem Cell-Derived Exosomes in Anterior Segment Eye Diseases: A Comprehensive Update Review. The Ocular Surface, 36, 209-219. [Google Scholar] [CrossRef] [PubMed]
[28] Zhao, D., Zhao, H., He, Y. and Zhang, M. (2024) BMSC Alleviates Dry Eye by Inhibiting the ROS-NLRP3-IL-1β Signaling Axis by Reducing Inflammation Levels. Current Eye Research, 49, 698-707. [Google Scholar] [CrossRef] [PubMed]
[29] Kobal, N., Marzidovšek, M., Schollmayer, P., Maličev, E., Hawlina, M. and Marzidovšek, Z.L. (2024) Molecular and Cellular Mechanisms of the Therapeutic Effect of Mesenchymal Stem Cells and Extracellular Vesicles in Corneal Regeneration. International Journal of Molecular Sciences, 25, Article 11121.
[30] Witt, J., Møller-Hansen, M., Borrelli, M., Holtmann, C., Heegaard, S. and Geerling, G. (2022) Jenseits von Ästhetik—regenerative medizin bei schweren erkrankungen der okulären adnexe. Die Ophthalmologie, 119, 878-890. [Google Scholar] [CrossRef] [PubMed]
[31] Loo, V.C., Kim, S., Johnson, L.M., Kay, H., Yi, A., Chen, J., et al. (2023) Preventing Potential Patient Harm through Clinical Content Interventions during Oncology Clinical Trial Implementation. Journal of Patient Safety, 19, 460-464. [Google Scholar] [CrossRef] [PubMed]
[32] Møller-Hansen, M., Larsen, A., Wiencke, A.K., Terslev, L., Siersma, V., Andersen, T.T., et al. (2024) Allogeneic Mesenchymal Stem Cell Therapy for Dry Eye Disease in Patients with Sjögren’s Syndrome: A Randomized Clinical Trial. The Ocular Surface, 31, 1-8. [Google Scholar] [CrossRef] [PubMed]
[33] Singh, S. and Basu, S. (2020) The Human Lacrimal Gland: Historical Perspectives, Current Understanding, and Recent Advances. Current Eye Research, 45, 1188-1198. [Google Scholar] [CrossRef] [PubMed]
[34] Rodboon, T., Yodmuang, S., Chaisuparat, R. and Ferreira, J.N. (2022) Development of High-Throughput Lacrimal Gland Organoid Platforms for Drug Discovery in Dry Eye Disease. SLAS Discovery, 27, 151-158. [Google Scholar] [CrossRef] [PubMed]